Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium

Figure 2

Outline of the pre-selection, the selection, the model building, and the validation procedure. (EOC, epithelial ovarian cancer; USC, uncorrelated shrunken centroids; SAM, significance analysis of microarrays; LASSO, L1 penalized logistic regression model; AUC, area under the receiver operating characteristic (ROC) curve; LMP, low malignant potential; n. s., not significant).

Back to article page